Annual Net Income
-$160.87 M
-$60.03 M-59.53%
December 31, 2024
Summary
- As of March 8, 2025, FDMT annual net profit is -$160.87 million, with the most recent change of -$60.03 million (-59.53%) on December 31, 2024.
- During the last 3 years, FDMT annual net income has fallen by -$89.55 million (-125.57%).
- FDMT annual net income is now -1584.31% below its all-time high of -$9.55 million, reached on December 31, 2018.
Performance
FDMT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$49.67 M
-$5.83 M-13.29%
December 31, 2024
Summary
- As of March 8, 2025, FDMT quarterly net profit is -$49.67 million, with the most recent change of -$5.83 million (-13.29%) on December 31, 2024.
- Over the past year, FDMT quarterly net income has dropped by -$14.72 million (-42.11%).
- FDMT quarterly net income is now -554.51% below its all-time high of -$7.59 million, reached on June 30, 2021.
Performance
FDMT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$160.87 M
-$17.39 M-12.12%
December 31, 2024
Summary
- As of March 8, 2025, FDMT TTM net profit is -$160.87 million, with the most recent change of -$17.39 million (-12.12%) on December 31, 2024.
- Over the past year, FDMT TTM net income has dropped by -$50.98 million (-46.39%).
- FDMT TTM net income is now -864.73% below its all-time high of -$16.68 million, reached on September 30, 2019.
Performance
FDMT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
FDMT Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -59.5% | -42.1% | -46.4% |
| 3 y3 years | -125.6% | -384.3% | -67.7% |
| 5 y5 years | -226.3% | -384.3% | -67.7% |
FDMT Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -125.6% | at low | -384.3% | at low | -125.6% | at low |
| 5 y | 5-year | -226.3% | at low | -554.5% | at low | -390.6% | at low |
| alltime | all time | -1584.3% | at low | -554.5% | at low | -864.7% | at low |
4D Molecular Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$160.87 M(+59.5%) | -$49.67 M(+13.3%) | -$160.87 M(+12.1%) |
| Sep 2024 | - | -$43.84 M(+25.4%) | -$143.48 M(+30.6%) |
| Jun 2024 | - | -$34.95 M(+7.9%) | -$109.89 M(+5.1%) |
| Mar 2024 | - | -$32.40 M(+0.4%) | -$104.56 M(+3.7%) |
| Dec 2023 | -$100.84 M(-6.2%) | -$32.28 M(+214.8%) | -$100.84 M(+5.1%) |
| Sep 2023 | - | -$10.26 M(-65.4%) | -$95.93 M(-13.9%) |
| Jun 2023 | - | -$29.62 M(+3.3%) | -$111.37 M(+1.4%) |
| Mar 2023 | - | -$28.68 M(+4.8%) | -$109.84 M(+2.2%) |
| Dec 2022 | -$107.49 M(+50.7%) | -$27.38 M(+6.6%) | -$107.49 M(+2.2%) |
| Sep 2022 | - | -$25.69 M(-8.5%) | -$105.20 M(+3.4%) |
| Jun 2022 | - | -$28.09 M(+6.6%) | -$101.75 M(+25.2%) |
| Mar 2022 | - | -$26.34 M(+5.0%) | -$81.25 M(+13.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$71.32 M(+25.8%) | -$25.08 M(+12.8%) | -$71.32 M(+6.8%) |
| Sep 2021 | - | -$22.24 M(+193.0%) | -$66.78 M(+27.5%) |
| Jun 2021 | - | -$7.59 M(-53.7%) | -$52.38 M(-12.6%) |
| Mar 2021 | - | -$16.41 M(-20.2%) | -$59.94 M(+5.7%) |
| Dec 2020 | -$56.69 M(+15.0%) | -$20.55 M(+162.3%) | -$56.69 M(+8.5%) |
| Sep 2020 | - | -$7.83 M(-48.3%) | -$52.26 M(-14.5%) |
| Jun 2020 | - | -$15.15 M(+15.1%) | -$61.10 M(+33.0%) |
| Mar 2020 | - | -$13.16 M(-18.3%) | -$45.95 M(+40.1%) |
| Dec 2019 | -$49.31 M(+416.2%) | -$16.11 M(-3.4%) | -$32.79 M(+96.6%) |
| Sep 2019 | - | -$16.68 M | -$16.68 M |
| Dec 2018 | -$9.55 M(-14.9%) | - | - |
| Dec 2017 | -$11.22 M | - | - |
FAQ
- What is 4D Molecular Therapeutics annual net profit?
- What is the all time high annual net income for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual net income year-on-year change?
- What is 4D Molecular Therapeutics quarterly net profit?
- What is the all time high quarterly net income for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly net income year-on-year change?
- What is 4D Molecular Therapeutics TTM net profit?
- What is the all time high TTM net income for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics TTM net income year-on-year change?
What is 4D Molecular Therapeutics annual net profit?
The current annual net income of FDMT is -$160.87 M
What is the all time high annual net income for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual net profit is -$9.55 M
What is 4D Molecular Therapeutics annual net income year-on-year change?
Over the past year, FDMT annual net profit has changed by -$60.03 M (-59.53%)
What is 4D Molecular Therapeutics quarterly net profit?
The current quarterly net income of FDMT is -$49.67 M
What is the all time high quarterly net income for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly net profit is -$7.59 M
What is 4D Molecular Therapeutics quarterly net income year-on-year change?
Over the past year, FDMT quarterly net profit has changed by -$14.72 M (-42.11%)
What is 4D Molecular Therapeutics TTM net profit?
The current TTM net income of FDMT is -$160.87 M
What is the all time high TTM net income for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high TTM net profit is -$16.68 M
What is 4D Molecular Therapeutics TTM net income year-on-year change?
Over the past year, FDMT TTM net profit has changed by -$50.98 M (-46.39%)